Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-022756

Options or other derivatives

  • SVP Finance / Interim CFO acquired 167,768 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gerber Brianna · SVP Finance / Interim CFO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-08-12 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +100,460 100,460 D
2022-08-12 Grant or award : show line 2 in the form Restricted Stock Unit +67,308 67,308 D
Loading xslF345X03/wf-form4_166035275685057.xml…